InvestorsHub Logo

salgovernale69

09/29/14 4:17 PM

#22843 RE: Ninja Master #22841

We definitely won't get data relating to ESMO now, as the company is linking their poster all over twitter now, likely as a reaction to the uproar they received from investors when no PR was released on the data. However, how does this change the opportunity for "unprecedented" things to follow? I'm as frustrated as the next guy that we haven't gotten the updates we all so badly want just yet but let's not be overly dramatic and act as if we've received some sort of bad news.

furbush87

09/29/14 4:18 PM

#22844 RE: Ninja Master #22841

Well I have no idea what B16 melanoma is (I think it is only in mice) so we have cured mouse Melanoma (somewhere a vet is trying to figure out how to make money with this)

On a serious note, I read an article on Forbes last week talking about the FDA and how they were restructuring their approval process. It gave me the impression that the FDA is giving out BTD prior to a trial, then providing extra regulatory supervision through the trial to ensure the company meets their requirements and can make changes as it goes. If ONCS has applied for that, it may not be them we are waiting on, but the FDA to give a thumbs up.
Just a thought, take it for what little it is worth